Evidence map›Paper›PMID 31166552›Full record

ArticleJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia2019

Melatonin effects on pulmonary tissue in the experimental model of Hepatopulmonary Syndrome.

Adriane Dal Bosco, Filipe Boeira Schedler, Josieli Raskopf Colares, Elisângela Gonçalves Schemitt, Renata Minuzzo Hartmann, Luiz Alberto Forgiarini Junior, Alexandre Simões Dias, Norma Possa Marroni

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Pineal hormone melatonin as an adjuvant treatment for COVID‑19 (Review).International journal of molecular medicine · 2021
    Review
  6. Is Melatonin the Cornucopia of the 21st Century?Antioxidants (Basel, Switzerland) · 2020
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Adriane Dal Bosco. Centro Universitário Metodista, Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0003-0907-8325
Filipe Boeira Schedler. Centro Universitário Metodista, Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0002-5518-2601
Josieli Raskopf Colares. Hospital de Clínicas de Porto Alegre, Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0002-0482-204X
Elisângela Gonçalves Schemitt. Hospital de Clínicas de Porto Alegre, Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0003-3015-0192
Renata Minuzzo Hartmann. Hospital de Clínicas de Porto Alegre, Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0001-8667-517X
Luiz Alberto Forgiarini Junior. Universidade LaSalle, Canoas (RS) Brasil.ORCID http://orcid.org/0000-0002-6706-2703
Alexandre Simões Dias. Hospital de Clínicas de Porto Alegre, Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0002-0609-4779
Norma Possa Marroni. Hospital de Clínicas de Porto Alegre, Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0001-7856-7953
Universidade Federal do Rio Grande do Sul · BRCentro Universitário Metodista IPA · BRHospital de Clínicas de Porto Alegre · BRUniversidade La Salle · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the pulmonary alterations of animals with Hepatopulmonary Syndrome (HPS) submitted to Biliary Duct Ligature (BDL), as well as the antioxidant effect of Melatonin (MEL).

methodsSixteen male Wistar rats, divided into four Sham groups: BDL group, Sham + MEL group and BDL + MEL. The pulmonary and hepatic histology, lipoperoxidation and antioxidant activity of lung tissue, alveolar-arterial O2 difference and lung / body weight ratio (%) were evaluated.

resultsWhen comparing the groups, could be observed an increase of vasodilation and pulmonary fibrosis in the BDL group and the reduction of this in relation to the BDL + MEL group. It was also observed significant changes in the activity of catalase, ApCO2, ApO2 in the LBD group when compared to the other groups.

conclusionThe use of MEL has been shown to be effective in reducing vasodilation, fibrosis levels and oxidative stress as well as gas exchange in an experimental HPS model.

Indexed as

AnimalsAntioxidantsArterial PressureBile DuctsBlood Gas AnalysisCatalaseDisease Models, AnimalGlutathione TransferaseHepatopulmonary SyndromeLigationLipid PeroxidationLiverLiver CirrhosisLungMaleMelatoninAntioxidantsCatalaseGlutathione TransferaseMelatoninThiobarbituric Acid Reactive Substances

Identifiers

PMID31166552
PMCPMC6715043
OpenAlexW2947075928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.